首页> 外文期刊>Microbiology >Deletion of the Candida albicans histidine kinase gene CHK1 improves recognition by phagocytes through an increased exposure of cell wall β-1,3-glucans
【24h】

Deletion of the Candida albicans histidine kinase gene CHK1 improves recognition by phagocytes through an increased exposure of cell wall β-1,3-glucans

机译:删除念珠菌蛋白酶蛋白激酶基因CHK1通过增加细胞壁β-1,3-葡聚糖的暴露来改善吞噬细胞的识别

获取原文
           

摘要

The pathogenic fungus Candida albicans is able to cover its most potent proinflammatory cell wall molecules, the β-glucans, underneath a dense mannan layer, so that the pathogen becomes partly invisible for immune cells such as phagocytes. As the C. albicans histidine kinases Chk1p, Cos1p and CaSln1p had been reported to be involved in virulence and cell wall biosynthesis, we investigated whether deletion of the respective genes influences the activity of phagocytes against C. albicans. We found that among all histidine kinase genes, CHK1 plays a prominent role in phagocyte activation. Uptake of the deletion mutant Δchk1 as well as the acidification of Δchk1-carrying phagosomes was significantly increased compared with the parental strain. These improved activities could be correlated with an enhanced accessibility of the mutant β-1,3-glucans for immunolabelling. In addition, any inhibition of β-1,3-glucan-mediated phagocytosis resulted in a reduced uptake of Δchk1, while ingestion of the parental strain was hardly affected. Moreover, deletion of CHK1 caused an enhanced release of interleukins 6 and 10, indicating a stronger activation of the β-1,3-glucan receptor dectin-1. In conclusion, the Chk1p protein is likely to be involved in masking β-1,3-glucans from immune recognition. As there are no homologues of fungal histidine kinases in mammals, Chk1p has to be considered as a promising target for new antifungal agents.
机译:致病性真菌念珠菌白醛汉语能够覆盖其最有效的促炎细胞壁分子,β-葡聚糖,在致密的人体层下方,使得病原体对免疫细胞如吞噬细胞部分是不可见的。作为C. alphicans组氨酸激酶CHK1P,COS1P和CasLN1P据报道涉及毒力和细胞壁生物合成,我们研究了各种基因的缺失是否影响吞噬细胞的吞噬细胞的活性。我们发现,在所有组氨酸激酶基因中,CHK1在吞噬细胞活化中起着突出的作用。与亲本菌株相比,对缺失突变体ΔChk1的吸收以及ΔChk1的酸化明显增加。这些改进的活性可以与突变体β-1,3-葡聚糖的增强可达性相关,用于免疫标签。此外,β-1,3-葡聚糖介导的吞噬作用的任何抑制导致ΔChk1的摄取降低,同时摄入父母菌株几乎不会受到影响。此外,CHK1的缺失引起了增强的白细胞介素6和10的释放,表明β-1,3-葡聚糖受体Dectin-1的更强活化。总之,CHK1P蛋白可能参与掩蔽免疫识别的β-1,3-葡聚糖。由于哺乳动物中没有真菌组氨酸激酶的同源物,CHK1P必须被认为是新的抗真菌剂的有希望的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号